Ticker Details
Medpace Holdings, Inc. Medpace Holdings Inc is a clinical contract research organisation. It is engaged in providing scientifically-driven clinical research-based drug and medical device development services to the biotechnology, pharmaceutical and medical device industries.
IPO Date:	August 11, 2016
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$13.57B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$3.37 | 1.80%
Avg Daily Range (30 D):	$5.49 | 1.27%
Avg Daily Range (90 D):	$9.93 | 2.10%

Institutional Daily Volume
Avg Daily Volume:	.28M
Avg Daily Volume (30 D):	.26M
Avg Daily Volume (90 D):	.33M

Trade Size
Avg Trade Size (Sh.):	43
Avg Trade Size (Sh.) (30 D):	19
Avg Trade Size (Sh.) (90 D):	22

Institutional Trades
Total Institutional Trades:	3,264
Avg Institutional Trade:	$6.93M
Avg Institutional Trade (30 D):	$14.81M
Avg Institutional Trade (90 D):	$17.99M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$8.48M
Avg Closing Trade (30 D):	$16.82M
Avg Closing Trade (90 D):	$21.89M
Avg Closing Volume:	41.22K

News

Jun 8, 2026 @ 6:00 PM Safirstein Law LLC Announces That A Class Action L... Source: Safirstein Law Llc

Jun 7, 2026 @ 9:55 PM MEDP DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR CO... Source: Rosen Law Firm

Jun 5, 2026 @ 4:00 PM Bronstein, Gewirtz & Grossman LLC Urges Medpace Ho... Source: Bronstein, Gewirtz & Grossman Llc

Jun 5, 2026 @ 12:46 AM ROSEN, A LEADING LAW FIRM, Encourages Veritone, In... Source: Rosen Law Firm

Jun 4, 2026 @ 11:18 PM MEDPACE DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL,... Source: Rosen Law Firm

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$16.22	$4.35	$4.76
Diluted EPS	$15.88	$4.28	$4.64
Revenue	$2.68B	$706.6M	$708.45M
Gross Profit	$778.59M	$196.33M	$205.32M
Net Income / Loss	$460.4M	$123.87M	$135.13M
Operating Income / Loss	$562.92M	$141.5M	$153.27M
Cost of Revenue	$1.9B	$510.28M	$503.13M
Net Cash Flow	$211.25M	$155.63M	$211.7M
PE Ratio